These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1186461)

  • 1. [Relations between the concentration of fibrinogen, thromboplastin time, thrombin time and reptilase time in patients treated with Arwin].
    Paar D; Klüken N
    Med Welt; 1975 Sep; 26(38):1700-1. PubMed ID: 1186461
    [No Abstract]   [Full Text] [Related]  

  • 2. The cleavage and inactivation of plasminogen activator inhibitor type 1 and alpha2-antiplasmin by reptilase, a thrombin-like venom enzyme.
    Urano T; Ihara H; Takada Y; Fujie M; Takada A
    Blood Coagul Fibrinolysis; 2000 Mar; 11(2):145-53. PubMed ID: 10759007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defibrinogenating enzymes.
    Bell WR
    Drugs; 1997; 54 Suppl 3():18-30; discussion 30-1. PubMed ID: 9360849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subunits and susceptibility of fibrins formed from bovine fibrinogen by arvin, reptilase, thrombin and staphylothrombin.
    Zajdel M; Wegrzynowicz Z; Sawecka J; Kopeć M
    Thromb Res; 1975 Apr; 6(4):337-44. PubMed ID: 1169826
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the actions of thrombin and the thrombin-like venom enzymes ancrod and batroxobin.
    Aronson DL
    Thromb Haemost; 1976 Aug; 36(1):9-13. PubMed ID: 1036831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of treatment with ancrod (Arwin) in 21 patients with chronic arterial occlusive disease].
    Rosendo A; Sala Planell E; Latorre J; Marinello J; Olba L; Rutllant ML
    Rev Clin Esp; 1982 Mar; 164(5):313-6. PubMed ID: 7100546
    [No Abstract]   [Full Text] [Related]  

  • 7. Soluble fibrin complex production and proteolysis during ancrod therapy.
    McKillop C; Edgar W; Prentice CR; Forbes CD
    Scott Med J; 1975 May; 20(3):139-40. PubMed ID: 127379
    [No Abstract]   [Full Text] [Related]  

  • 8. Ancrod revisited: viscoelastic analyses of the effects of Calloselasma rhodostoma venom on plasma coagulation and fibrinolysis.
    Nielsen VG
    J Thromb Thrombolysis; 2016 Aug; 42(2):288-93. PubMed ID: 26905070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased thrombin generation and fibrinogen level after therapeutic plasma transfusion: relation to bleeding.
    Schols SE; van der Meijden PE; van Oerle R; Curvers J; Heemskerk JW; van Pampus EC
    Thromb Haemost; 2008 Jan; 99(1):64-70. PubMed ID: 18217136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating thrombin time anticoagulant in a procainamide-induced syndrome.
    Galanakis DK; Newman J; Summers D
    JAMA; 1978 May; 239(18):1873-4. PubMed ID: 642115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reptilase-R--a new reagent in blood coagulation.
    Funk C; Gmür J; Herold R; Straub PW
    Br J Haematol; 1971 Jul; 21(1):43-52. PubMed ID: 5105276
    [No Abstract]   [Full Text] [Related]  

  • 12. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blood coagulation in 222 cases of solid malignant neoplasms].
    Padoan AM; Di Tommaso A; Zerbinati C; Lo Monaco I; Nascimbeni O; Della Giustina L; Padovan L; Papaccio G; Tenchini P
    Chir Ital; 1985 Feb; 37(1):3-16. PubMed ID: 3995662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of simple coagulation tests (fibrinogen assays and thrombin coagulase clotting time) in the diagnosis of liver cancer.
    Pengo V; Levi Minzi S; Dal Bo Zanon R; Cappellato G; Farinati F; Girolami A
    J Med; 1984; 15(2):149-60. PubMed ID: 6096471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheological studies of creep and creep recovery of unligated fibrin clots: comparison of clots prepared with thrombin and ancrod.
    Bale MD; Müller MF; Ferry JD
    Biopolymers; 1985 Mar; 24(3):461-82. PubMed ID: 3986291
    [No Abstract]   [Full Text] [Related]  

  • 16. [In vitro effects of hemocoagulase atrix and its effective components on blood coagulation of patients with bleeding disorders].
    Wang RJ; Wang ZY; Jiang MH; Zhang W; Cao LJ; Sun XH; Zhang J; Bai X; Ruan CG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):376-80. PubMed ID: 22541102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysfibrinogenemia and lupus anticoagulant in a patient with recurrent thrombosis.
    Al-Mondhiry H; Galanakis D
    J Lab Clin Med; 1987 Dec; 110(6):726-33. PubMed ID: 3119749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clotting of fibrinogen. 2. Calorimetry of the reversal of the effect of calcium on clotting with thrombin and with ancrod.
    Mihalyi E; Donovan JW
    Biochemistry; 1985 Jul; 24(14):3443-8. PubMed ID: 3929831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of coagulation factors on intrinsic thrombin generation.
    Stief TW; Otto S; Renz H
    Blood Coagul Fibrinolysis; 2007 Jan; 18(1):67-71. PubMed ID: 17179830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reptilase time (RT).
    Karapetian H
    Methods Mol Biol; 2013; 992():273-7. PubMed ID: 23546720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.